Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
Phase 4
Completed
- Conditions
- Dry Eye Due to Sjögren's Syndrome
- Interventions
- Drug: LO2A eye drops
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 60
- Registration Number
- NCT03319420
- Locations
- 🇮🇱
HaEmek MC, Afula, Israel
🇮🇱Rambam, Haifa, Israel
🇮🇱Rabin MC, Petah tikva, Israel
To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis
Phase 2
Completed
- Conditions
- Conjunctivochalasis
- Interventions
- Drug: LO2ADrug: Placebo
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 13
- Registration Number
- NCT02810119
- Locations
- 🇮🇱
Barzilai MC, Ashkelon, Israel
Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis
Phase 2
Completed
- Conditions
- Conjunctivochalasis
- Interventions
- Drug: LO2ADrug: Saline
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 62
- Registration Number
- NCT02804191
- Locations
- 🇮🇱
Rambam, Haifa, Israel
🇮🇱Hadassah, Jerusalem, Israel
🇮🇱Ichilov Tel Aviv hospital, Tel Aviv, Israel
News
No news found